Can ParC Ser83Ile status predict fluoroquinolone efficacy in Mycoplasma genitalium infection? - Authors' reply.
Saved in:
| Title: | Can ParC Ser83Ile status predict fluoroquinolone efficacy in Mycoplasma genitalium infection? - Authors' reply. |
|---|---|
| Authors: | Sweeney EL; The University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia. Electronic address: e.l.sweeney@uq.edu.au., Bradshaw CS; Melbourne Sexual Health Centre, Alfred Hospital and Central Clinical School, Carlton, VIC, Australia., Murray GL; The Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC, Australia; Centre for Women's Infectious Diseases, The Royal Women's Hospital, Parkville, VIC, Australia; Molecular Microbiology Research Group, Murdoch Children's Research Institute, Parkville, VIC, Australia., Whiley DM; The University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia; Pathology Queensland Central Laboratory, Brisbane, QLD, Australia. |
| Source: | The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Sep; Vol. 22 (9), pp. 1274-1275. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
